HIV does lower white blood cell counts, and it does so through multiple pathways. The virus directly destroys CD4 T cells, a critical subset of white blood cells, while also disrupting the bone marrow’s ability to produce new blood cells. A healthy person has between 500 and 1,500 CD4 cells per cubic millimeter of blood. Without treatment, HIV can drive that number below 200, the threshold that defines an AIDS diagnosis.
How HIV Destroys White Blood Cells
HIV targets CD4 T cells specifically because it uses a protein on their surface as its entry point. Once inside, the virus hijacks the cell’s machinery to make copies of itself, eventually killing the host cell. What makes this especially damaging is that HIV preferentially infects CD4 cells that are actively fighting HIV itself, meaning the very immune cells trying to control the infection are the ones being destroyed fastest.
The destruction happens in two phases. During the acute phase, shortly after infection, there’s a dramatic loss of CD4 cells concentrated in the gut lining, where a large portion of immune tissue lives. This first wave of destruction happens before the body can mount a meaningful defense. Then comes a chronic phase, where persistent inflammation triggers an ongoing, gradual decline in CD4 cells circulating through the bloodstream. The immune system stays in a state of constant activation, which paradoxically accelerates cell death through a process called apoptosis, where immune cells essentially self-destruct.
Beyond directly killing cells, HIV also causes white blood cell loss through other mechanisms: it impairs the thymus gland’s ability to produce new T cells, causes infected cells to fuse together into dysfunctional clumps, and marks infected cells for destruction by the body’s own killer T cells.
The Bone Marrow Problem
HIV doesn’t just destroy mature white blood cells in the bloodstream. It also reaches into the bone marrow, where all blood cells are produced from stem cells. Studies have found that HIV infection reduces the number of these stem cells and impairs their ability to develop into functioning white blood cells, red blood cells, and platelets. This means the body’s blood cell factory slows down at the same time the virus is destroying its products.
The result can be pancytopenia, a condition where all major blood cell types are low simultaneously. The production of lymphocytes (the white blood cell family that includes CD4 cells), neutrophils (the white blood cells that fight bacterial and fungal infections), and even red blood cells can all be disrupted during HIV infection. One protein produced by HIV, called Nef, has been shown to specifically interfere with how stem cells develop into T cells and other immune cells.
Which White Blood Cells Are Affected
While CD4 T cells get the most attention, HIV lowers several types of white blood cells. In one study of HIV patients who had not yet started treatment, 26.7% had leukopenia (low total white blood cell count), 20% had lymphopenia (low lymphocyte count), and 16.5% had neutropenia (low neutrophil count). About one in four also had low platelet counts.
Neutropenia is particularly concerning because neutrophils are the body’s first responders against bacterial and fungal infections. When neutrophil counts drop below 750 cells per cubic millimeter, the risk of these infections rises. Below 500, the risk of serious infection requiring hospitalization climbs significantly. That said, neutropenia on its own has not been linked to decreased survival in HIV-positive women, though data on men is limited.
What Happens After Starting Treatment
Antiretroviral therapy (ART) suppresses HIV replication, which allows the immune system to begin rebuilding. The recovery can be surprisingly fast in the early months. In a large study of patients starting treatment with a median CD4 count of 264, the median count rose to 472 within 12 months, an increase of about 148 cells. Nearly 58% of patients gained more than 100 CD4 cells in that first year, and about half reached a CD4 count above 500, which falls within the normal range.
Most antiretroviral medications actually help correct low white blood cell counts as viral suppression takes hold. The major exception is zidovudine, an older drug that can cause neutropenia as a side effect due to its toxicity to bone marrow. Other ART regimens generally resolve neutropenia as CD4 counts improve and viral load drops. Current guidelines recommend monitoring CD4 counts every six months until they stay above 250 for a full year, at which point routine monitoring can typically stop.
How Low Counts Signal HIV
An unexpectedly low white blood cell count on routine bloodwork can sometimes be the first clue that someone has HIV. A total WBC count that’s below normal, especially when lymphocytes are disproportionately low, is a pattern that often prompts further testing. The CDC defines an AIDS diagnosis as a CD4 count below 200, but significant immune suppression begins well before that point. Many people experience increased susceptibility to infections once CD4 counts drop below 350.
If you’ve had bloodwork showing low white blood cell counts without an obvious explanation, HIV testing is one of the standard steps in working out the cause. The connection between HIV and low WBC counts is well established enough that unexplained leukopenia, particularly with low lymphocyte counts, is a recognized reason to screen for the virus.